Page last updated: 2024-08-26

1,4-dihydropyridine and Cystic Fibrosis of Pancreas

1,4-dihydropyridine has been researched along with Cystic Fibrosis of Pancreas in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Caci, E; Diena, T; Galietta, LJ; Mazzei, M; Nieddu, E; Pedemonte, N; Ravazzolo, R; Zegarra-Moran, O	1

Other Studies

1 other study(ies) available for 1,4-dihydropyridine and Cystic Fibrosis of Pancreas

Article	Year
Antihypertensive 1,4-dihydropyridines as correctors of the cystic fibrosis transmembrane conductance regulator channel gating defect caused by cystic fibrosis mutations. Molecular pharmacology, 2005, Volume: 68, Issue:6 Topics: Animals; Antihypertensive Agents; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dihydropyridines; Electrophysiology; Ion Channel Gating; Mice; Mutation; Rats; Rats, Inbred F344; Thyroid Gland; Transfection	2005

Article

Year

Antihypertensive 1,4-dihydropyridines as correctors of the cystic fibrosis transmembrane conductance regulator channel gating defect caused by cystic fibrosis mutations.

Molecular pharmacology, 2005, Volume: 68, Issue:6

Topics: Animals; Antihypertensive Agents; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dihydropyridines; Electrophysiology; Ion Channel Gating; Mice; Mutation; Rats; Rats, Inbred F344; Thyroid Gland; Transfection

2005